Medical Wellness8 min readJune 27, 2026

Hormone Replacement Therapy: What to Know Before You Start

Hormone replacement therapy can be life-changing for the right patient, but it should never be treated like a wellness trend or a one-size-fits-all protocol. Hot flashes, sleep disruption, mood changes, brain fog, vaginal dryness, weight shifts, low libido, and cycle changes deserve a careful clinical conversation. This guide explains what HRT can and cannot do, which labs and history details matter, and how Devorah evaluates hormone care for patients in New York State.

Devorah, DNP, APRN, FNP-BC

Board-Certified Nurse Practitioner · Bee the NP

What hormone replacement therapy actually means

Hormone replacement therapy, often called HRT or menopausal hormone therapy, uses estrogen, progesterone, and sometimes testosterone to treat symptoms related to changing hormone levels. For many women, the most relevant window is perimenopause: the years before menopause when estrogen and progesterone fluctuate unpredictably. Symptoms can appear even when periods are still happening and basic labs look normal.

HRT is not one treatment. The details matter: estrogen can be delivered through a patch, gel, spray, ring, or pill; progesterone may be needed to protect the uterine lining when a patient has a uterus; vaginal estrogen can treat genitourinary symptoms with very low systemic exposure. Testosterone is a separate discussion and is not appropriate for every patient. A useful hormone plan starts by matching the symptom pattern, medical history, risk profile, and route of therapy.

Symptoms that may point to a hormone transition

The classic menopause symptom is hot flashes, but hormone changes often show up more subtly. Patients may notice waking at 3 a.m., night sweats, new anxiety, irritability, heavier or irregular periods, migraines that change pattern, joint aches, dry skin, vaginal dryness, painful intercourse, recurrent urinary symptoms, lower libido, or a sudden feeling that their body is not responding the way it used to.

These symptoms overlap with thyroid dysfunction, iron deficiency, insulin resistance, sleep disruption, medication side effects, chronic stress, and under-fueling. That is why Devorah does not treat every midlife symptom as automatically hormonal. The clinical work is sorting out which pieces are hormone-driven, which are metabolic or nutritional, and which require a different medical workup.

Labs help, but timing and interpretation matter

Hormone labs can be useful, but they are not magic answers. In perimenopause, estrogen and progesterone may swing dramatically from week to week, so a single normal result does not rule out a hormone transition. FSH and estradiol can support the picture, especially when interpreted with cycle timing and symptoms. Progesterone is most meaningful when timed to the luteal phase in cycling patients. Testosterone testing should include context such as SHBG and symptoms rather than relying on total testosterone alone.

Devorah also looks beyond sex hormones because many 'hormone' complaints have multiple drivers. A thoughtful workup may include thyroid markers, CBC, ferritin and iron studies, vitamin D, B12, folate, HbA1c, fasting insulin, lipids, liver and kidney function, and inflammatory markers when appropriate. The goal is not to order the biggest panel. The goal is to find the markers that change the plan.

Benefits HRT may provide for the right patient

For appropriately selected patients, HRT is one of the most effective treatments for vasomotor symptoms such as hot flashes and night sweats. It can also improve sleep when sleep disruption is driven by night sweats, support mood stability for some patients, improve vaginal and urinary symptoms, reduce painful intercourse related to low estrogen, and help preserve bone density during and after the menopause transition.

HRT is not a guaranteed solution for every concern. It should not be promised as a universal fix for weight gain, fatigue, libido, or mood. Those symptoms may improve when hormones are a major driver, but they also depend on sleep, stress, nutrition, muscle mass, insulin sensitivity, thyroid function, medications, and relationship or life context. The most honest approach is to define the target symptoms before starting, then reassess whether the treatment is actually helping.

Risks, contraindications, and why route matters

HRT decisions are individualized because risk depends on age, time since menopause, personal and family history, dose, route, and formulation. Patients with a history of certain hormone-sensitive cancers, unexplained vaginal bleeding, active liver disease, prior blood clot or stroke, or high-risk cardiovascular history need careful evaluation and may not be candidates for systemic therapy. Mammogram status, blood pressure, migraine history, smoking, clotting risk, and medication list all matter.

Route of estrogen can change the risk conversation. Transdermal estrogen, such as a patch or gel, avoids first-pass liver metabolism and may be preferable for some patients with clotting or metabolic concerns compared with oral estrogen. Progesterone choice also matters: micronized progesterone has a different side-effect and risk profile than some synthetic progestins. These details are why HRT should be supervised medically rather than copied from a generic online protocol.

Compounded and bioidentical hormones: what to understand

The word 'bioidentical' can be confusing. Some FDA-approved hormone products are bioidentical, meaning the molecule matches what the body makes. Compounded hormones can also be bioidentical, but compounded does not automatically mean safer, more natural, or better. It can mean less standardization, variable dosing, and less safety data depending on the product and pharmacy.

There are situations where compounding may be considered, such as a specific allergy, unavailable dose, or route that is not commercially available. But it should be chosen for a clinical reason, not because marketing makes it sound cleaner. Devorah's priority is a plan that is effective, measurable, and medically safe: the right molecule, route, dose, monitoring plan, and follow-up.

How Devorah approaches hormone conversations

A hormone visit starts with the full story: symptoms, cycle pattern, pregnancy history when relevant, contraception, migraines, sleep, mood, libido, vaginal or urinary symptoms, weight changes, family history, cancer screening, medications, supplements, and what the patient wants to feel better. Devorah pairs that story with targeted labs and preventive care context so the plan is grounded instead of reactive.

For New York patients, the advantage of Bee the NP's one-provider model is continuity. Hormone care often requires follow-up: adjusting a dose, changing a route, checking side effects, reviewing bleeding patterns, reassessing labs, and deciding whether the original goals are being met. You are not handed a static protocol. You work directly with Devorah to decide what is appropriate, what needs monitoring, and when another explanation deserves attention.

Key takeaways

HRT can include estrogen, progesterone, vaginal estrogen, and sometimes testosterone, but the details depend on symptoms and risk profile
Perimenopause symptoms can happen before periods stop and may overlap with thyroid, iron, insulin, sleep, and stress issues
Labs are useful when timed and interpreted correctly; one normal hormone result does not rule out a transition
HRT is strongest for hot flashes, night sweats, genitourinary symptoms, sleep disrupted by vasomotor symptoms, and bone support
Medical history, cancer screening, clot risk, migraine history, blood pressure, and route of therapy all matter for safety
Devorah uses a one-provider model for New York patients, with follow-up and monitoring instead of generic hormone protocols